Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chondroitin Sulfate fMRI Study in Knee OA
NCT01226615Phase 4Unknown
- Sponsor
- Bioiberica
- Start
- Oct 2010
- Primary completion
- Oct 2011
- Modality
- Biomacromolecule, Polysaccharide, GAG (Glycosaminoglycan)
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in osteoarthritis (OA) comparing Chondroitin sulphate with Placebo (2 arms). Primary endpoint: Brain response to pain caused on arthritic knee selected by fMRI at 4 months. Status: unknown.
02
Drugs
chondroitin sulfate
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT01226615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01226615.